Quick Answer
BIOVIE INC. reported R&D Expense of $9.27 million for fiscal year 2025.
BIOVIE INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.27M | -59.9% |
| 2024 | $23.10M | -30.6% |
| 2023 | $33.30M | +92.9% |
| 2022 | $17.26M | +578.2% |
| 2021 | $2.54M | +121.2% |
| 2020 | $1.15M | +14.1% |
| 2019 | $1.01M | +171.8% |
| 2018 | $370.9K | -20.5% |
| 2017 | $466.4K | +1130.5% |
| 2016 | $37.9K | +803.3% |
| 2015 | $4.2K | -91.5% |
| 2014 | $49.4K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.27M | -9.3% | +45.4% |
| September 30, 2025 | $2.94M | +47.5% | +118.3% |
| March 31, 2025 | $1.34M | -76.4% | -71.4% |
| December 31, 2024 | $4.70M | -27.3% | +136.4% |
| September 30, 2024 | $1.99M | -77.6% | -65.1% |
| March 31, 2024 | $5.70M | -49.1% | -11.9% |
| December 31, 2023 | $6.47M | -8.0% | -27.1% |
| September 30, 2023 | $8.88M | +31.1% | -20.7% |
- BIOVIE INC. showed a decrease of -59.9% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, BIOVIE INC.’s r&d expense has grown by 18651.4% (from $49.4 thousand to $9.27 million).
- The most recent figure is from BIOVIE INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: